Lymph node staging is determinant in the management of cancer patients. Noninvasive imaging modalities have limited accuracy to distinguish malignant form benign lymph nodes. For that purpose, we investigated putative nonexponential (multicompartmental) and potentially non-monotonic decay in simple multi-gradient-echo(MGE) MRI in colorectal cancer. We find that frequency offsets arising from multicompartment models distinguish malignancy from normal tissues (as identified from histopathology), while relaxation rates or fractions do not. Such experiments are potentially suggestive of a simple yet useful tool for nodal staging.
All experiments were approved by local ethics committee. Nine malignant and 9 benign nodes from 6 patients histopathologically staged as node positive after local resection, without neoadjuvant therapy, were included. Nodes were preserved in 4% formaldehyde and moved to 1% PBS solution 24h before scanning.
Image acquisition
Nodes were immersed in Flourinert® and acquired at 37ºC in a 16.4T Bruker Ascend Aeon scanner using a Micro5 NMR probe capable of producing up to 3000 mT/m in all directions. A fat-suppressed MGE sequence was applied using 50 TEs starting at 1.6 ms with 1.4 ms interval, TR=1500 ms, FA=50º; slice thickness:0.3mm; in-plane resolution=(0.1mm)2, Bandwidth:125kHz, 25 averages.
T2* signal decay model
Magnitude data were fitted using 1-, 2- and 3-compartment models described below:
$$$ S1C(TE) = S0 exp(-TE/T2*) $$$
$$$ S2C(TE) = S0|f1exp(-TE/T2*1) + (1-f1)exp(-TE(1/T2*2 + iΔΩ))| $$$
$$$S3C(TE) = S0|f1exp(-TE/T2*1) + f2exp(-TE(1/T2*2 + iΔΩ1)) + (1-f1-f2)exp(-TE(1/T2*3 + iΔΩ2))| $$$
where TE is the echo time, S0 is the signal at TE=0, and T2*i represents the relaxation time of compartment i with a volume fraction fi and frequency shift ΔΩ.
Image analysis
MRI datasets were smoothed in k-space (Gaussian filter with standard deviation of 5000) and analyzed in Matlab®. Models were fitted voxel-wise using a constrained non-linear optimization procedure accounting for Rician noise. Whole-node ROIs and 3 individual ROIs were defined, the latter placed in the cortex of benign nodes and in tumour-infiltrated areas, guided by histology (Figure 1). Paramateric maps were obtained from fits to each model (Figure 2).
Statistics
A non-parametric test was applied given data was not normally distributed.
The ex-vivo application of 2- and 3-compartment models of T2* decay to an MGE MRI acquisition resulted in ΔΩ values that were consistently lower in tumour-infiltrated than in benign lymph nodes from colorectal cancer patients.
Teresa Duarte, Champalimaud Research, Champalimaud Centre for the Unknown, Lisbon, Portugal
Rita Gil, Champalimaud Research, Champalimaud Centre for the Unknown, Lisbon, Portugal
Daniel Nunes, Champalimaud Research, Champalimaud Centre for the Unknown, Lisbon, Portugal
António Gomes, Hospital Fernando Fonseca EPE, Lisbon, Portugal
António Beltran, Champalimaud Centre for the Unknown, Lisbon, Portugal
Lara Castanheira, Champalimaud Centre for the Unknown, Lisbon, Portugal
Alexandra Martins, Champalimaud Centre for the Unknown, Lisbon, Portugal
(1) Bipat S, Afina GS, Slors FJM, Zwinderman AH, Bossuyt PMM, Stoker J. Rectal Cancer: Local Staging and Assessment of Lymph Node Involvement with Endoluminal US, CT, and MR Imaging—A Meta-Analysis. Radiology 2004; 232:773–783.
(2) Korteweg MA, Zwanenburge JJM, Hoogduin JM, van der Bosch AAJ, van Diest PJ, van Hillegersberg R, Eijkemans JC et al. Dissected sentinel lymph nodes of breast cancer patients: characterization with high-spatial-resolution 7-T MR imaging. Radiology. 2011. 261: 127-135.
(3) Li C, Meng S, Yang X, Wang J and Hu J. The value of T2* in differentiation metastatic from benign axillary lymph nodes in patients with breast cancer – a preliminary in vivo study. PloS One. 2014. 9(1):e84038.
(4) Sati P, van Gelderen P, Silva AC, Reich DS, Merkle H, Zwart JA and Duyn JH. Micro-compartment specific T2* relaxation in the brain. NeuroImage. 2013. 77:268-278. (5) Qian Y, Williams A A, Chu C R and Boada F E. Multicomponent T2* mapping of knee cartilage: technical feasibility ex vivo. Magn Reson Med. 2010. 64:1427-1432.
(5) Qian Y, Williams A A, Chu C R and Boada F E. Multicomponent T2* mapping of knee cartilage: technical feasibility ex vivo. Magn Reson Med. 2010. 64:1427-1432.
(6) Koch KM, Papademetris X, Rothman DL, de Graaf RA. Rapid calculations of susceptibility-induced magnetostatic field perturbations for in vivo magnetic resonance. Phys Med Biol. 2006. 21;51(24):6381-402.